Patrick Verschueren

Full Professor

Katholieke Universiteit Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Patrick Verschueren is a Full Professor at Katholieke Universiteit Leuven Faculteit Geneeskunde, Belgium. His research primarily focuses on inflammatory conditions, particularly psoriatic arthritis and rheumatoid arthritis, as evidenced by his recent publications on biomarkers, self-management applications, and treatment efficacy. He is actively engaged in studies aimed at improving patient care and understanding disease mechanisms in immune-mediated inflammatory diseases.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Hans Kromhout

Utrecht University

NETHERLANDS

View details

Hendrik Schulze‐Koops

GERMANY

View details

Tom Huizinga

prof

Leiden University Medical Center

NETHERLANDS

View details

Jo Lambert

Prof Dr

Ghent University Hospital

BELGIUM

View details

Paul Studenic

Karolinska Institutet

SWEDEN

View details

Bernard Combe

Professor of Rheumatology, Head of the department of Rheumatology, Head of the medical and surgical bones and joint departments

University of Montpellier

FRANCE

View details

Denis Mulleman

Professor

Université de Tours

FRANCE

View details

Triana Lobaton Ortega

Ghent University Hospital

BELGIUM

View details

Tsutomu Takeuchi

Keio University School of Medicine

JAPAN

View details

Robert Landewé

Professor

Amsterdam University Medical Centers

NETHERLANDS

View details

Guenter Steiner

Head of Research Laboratory

Medical University of Vienna

AUSTRIA

View details

Andreas Kerschbaumer

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Verschueren

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive protein

A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial

Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritis

Classification of rheumatoid arthritis: is it time to revise the criteria?

Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study

Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)

Occupational history questionnaire for job coding and exposure assessment in systemic autoimmune rheumatic diseases

New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens

Physician estimates of inflammation, damage and distress in rheumatoid arthritis: how can they be used to improve patient care?

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhiret al

What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

Collaborators (12)

Hans Kromhout

Hendrik Schulze‐Koops

Tom Huizinga

Jo Lambert

Paul Studenic

Bernard Combe

Denis Mulleman

Triana Lobaton Ortega

Tsutomu Takeuchi

Robert Landewé

Guenter Steiner

Andreas Kerschbaumer

Make your next move.